FUJIFILM Diosynth Biotechnologies Announces $55 Million USD Investment To Expand Gene Therapy Development Capabilities
FUJIFILM Diosynth Biotechnologies will be expanding its gene therapy process and analytical development capabilities with the addition of new dedicated laboratorios. FUJIFILM Diosynth Biotechnologies (FDB), a leading global biologics Contract Development and Manufacturing Organization (CDMO) has announced the expansion of
Enterome Enters Collaboration With Major Cancer Center Focused on New Microbiome-derived Immunotherapies
ENTEROME, a clinical-stage biopharmaceutical company leveraging its unique knowledge of the key functional and molecular interactions between the gut microbiome and the human body to develop targeted therapeutics, has entered into a research collaboration with Memorial Sloan Kettering Cancer Center
Coherus as Marketing and Distribution Partner for Bioeq and Its Biosimilar to Lucentis (ranibizumab) in the US
Bioeq announced that it signed a license and development agreement with Coherus BioSciences, under which Coherus will exclusively market and distribute Bioeq's biosimilar candidate to Lucentis (ranibizumab) in the United States. Coherus BioSciences is a leading biosimilar company that develops and
PredictImmune signs agreement with Theradiag to Commercialise PredictSURE IBD in French speaking Europe
PredictImmune, developers of pioneering prognostic tools for guiding treatment options in immune-mediated diseases, confirmed that it has entered into a commercial partnership with Theradiag, a pioneering European diagnostic company specialising in in vitro diagnostics and theranostics for autoimmune diseases and
Zentiva Acquires Manufacturing Site in Ankleshwar, India
Zentiva Group announces the signing of a Business Transfer Agreement with Sanofi to acquire their manufacturing site in Ankleshwar, India. This acquisition will help ensure the continued supply of high-quality medicines to more patients by expanding the footprint and agility
Atomwise Announces Largest China-US Collaboration for AI Drug Discovery
Atomwise, the leader in artificial intelligence (AI) for drug discovery, today announced a collaboration with Hansoh Pharmaceutical Group Company Limited (“Hansoh Pharma”), a leading biopharmaceutical company in China, to design and discover potential drug candidates for up to eleven undisclosed
Grünenthal and Mesoblast Enter Strategic Partnership for Europe and Latin America to Develop and Commercialise Innovative Cell Therapy for the Treatment of Chronic Low Back Pain
Grünenthal, a global leader in pain management, and Mesoblast Limited, a world leader in allogeneic cellular medicines for inflammatory diseases, announced that they have entered into a strategic partnership to develop and commercialise MPC-06-ID, a Phase III allogeneic cell therapy